Tower Research Capital »

Carmell Therapeutics Corp - US shares owned by Tower Research Capital

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.9k 2.2k 1.33
2024-03-31 $3.3k 1.3k 2.56
2023-09-30 $3.2k 881 3.60

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Tower Research Capital
Morgan Stanley
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US